pSivida Corp

Committee Composition

  Audit Governance and Nominating Compensation
Dr. David J. Mazzo Independent Director     Committee Chair for Compensation Committee
David Mazzo Non Executive Chairman

Dr. Mazzo is the Chief Executive Officer and a Director at Caladrius Biosciences. Prior to joining Caladrius (formerly NeoStem), Dr. Mazzo served as Chief Executive Officer and as Director of Regado Biosciences, a company focused on the development of novel anti-thrombotic drug systems for acute and sub-acute cardiovascular indications. Dr.Mazzo was also Chief Executive Officer and Director of Aeterna Zentaris, Inc. and Chief Executive Officer and Director at Chugai Pharma USA LLC,a biopharmaceutical company. Dr. Mazzo has also held senior management and executive positions in research and development and was a Director of the Essex Chimie European subsidiary at Schering-Plough Corporation. Dr.Mazzo earned a B.A. in the Honors Program (Interdisciplinary Humanities) and a B.S. in Chemistry from Villanova University. In addition, Dr.Mazzo received his M.S. in Chemistry and his Ph.D. in Analytical Chemistry from the University of Massachusetts, Amherst.


Mr. Douglas Godshall Independent Director   Member of Governance and Nominating Committee Member of Compensation Committee
Mr. Michael W. Rogers Independent Director Committee Chair for Audit Committee Member of Governance and Nominating Committee Member of Compensation Committee
Committee Chair = Chair Committee Member = Member Independent Director = Independent Director

Search Investor Relations

pSivida